(Q34724275)

4 August 2017

1 reference

title

Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review (English)

1 reference

4 August 2017

Rush CR

1

1 reference

4 August 2017

Higgins ST

series ordinal

2

1 reference

4 August 2017

Bickel WK

series ordinal

3

1 reference

4 August 2017

Hughes JR

series ordinal

4

1 reference

4 August 2017

publication date

1 January 1993

1 reference

Neuroscience & Biobehavioral Reviews

4 August 2017

published in

1 reference

4 August 2017

volume

17

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

277-285

1 reference

Preference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during the follow-up phase.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Effectiveness of triazolam, diazepam, and placebo as preanesthetic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Repeated diazepam administration: effects on the acquisition and performance of response chains in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

The effects of diazepam and triazolam on repeated acquisition and performance of response sequences with an observing response

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Next-day memory impairment with triazolam use

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Alprazolam and lorazepam effects on memory acquisition and retrieval processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

A review of alprazolam withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Effects of combined alcohol and benzodiazepine: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Intravenous diazepam in humans: effects on acquisition and performance of response chains.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Testing the abuse liability of anxiolytic and hypnotic drugs in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Adverse effects of antianxiety drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Acute overdosage with benzodiazepine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Benzodiazepines: a summary of pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Relative abuse liability of triazolam: experimental assessment in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Relative Abuse Liability of Different Benzodiazepines in

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Alprazolam and diazepam: addiction potential

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Benzodiazepines and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Antianxiety Drugs and Human Performance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Benzodiazepine Dependence A Review of the Evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Hypnotics and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Benzodiazepine withdrawal: overview and implications for the treatment of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

A comparison of the acute behavioral effects of triazolam and temazepam in normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Long-term Therapeutic Use of Benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Dependence-producing properties of alprazolam in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980011-9

7 January 2021

10.1016/S0149-7634(05)80011-9

Identifiers

DOI

1 reference

4 August 2017

1 reference